Urol. praxi. 2022;23(3):131-136 | DOI: 10.36290/uro.2022.036

Herbal preparations in trealing benign prostatic hyperplasia

PharmDr. Alice Sychrová, Ph.D.
Ústav přírodních léčiv, Farmaceutická fakulta, Masarykova univerzita, Brno

Benign prostatic hyperplasia affects men from the age of 40 and its prevalence increases with age. Millions of men worldwide suffer from this disease, with many of them choosing an alternative treatment approach using phytotherapeutics, which are available in the form of registered preparations or food supplements. These preparations contain extracts that have been tested in clinical studies. Many of these studies have been critically evaluated by systematic reviews and meta-analyses. Recent data shows that saw palmetto (Serenoa repens) has a significant effect. Other drugs used in the treatment of BPH/LUTS include stinging nettle, lycopene, pumpkin, pygeum and rye pollen. However, the results of studies cannot be extrapolated to specific products unless proper extraction techniques, phytochemical analysis and dosage have been followed. The present paper aims to provide an overview of the latest know­ledge in the field of BPH/LUTS phytotherapy with an emphasis on the clinical effect, side effects, interactions and rational dosage.

Keywords: benign prostatic hyperplasia, lycopene, nettle, pumpkin, pygeum, rye pollen, saw palmetto.

Accepted: October 10, 2022; Published: October 12, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sychrová A. Herbal preparations in trealing benign prostatic hyperplasia. Urol. praxi. 2022;23(3):131-136. doi: 10.36290/uro.2022.036.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Leisegang K, Jimenez M, Durairajanayagam D, et al. A systematic review of herbal medicine in the clinical treatment of benign prostatic hyperplasia. Phytomed. Plus. 2022;2(1):100153. Go to original source...
    2. Lee SWH, Chan, EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci. Rep. 2017;7(1):1-10. Go to original source... Go to PubMed...
    3. Dhami N, Mishra AD. Phytochemical variation: how to resolve the quality controversies of herbal medicinal products? J. Herb. Med. 2015;5(2):118-127. Go to original source...
    4. SÚKL. Rozlišení doplňků stravy od léčivých přípravků [on-line]. Praha. ©2010. [cit. 08-09-2022]. Available from: https://www.sukl.cz/leciva/rozliseni-doplnku-stravy-od-lecivych-pripravku.
    5. Gafner S. Saw palmetto extract laboratory guidance document [online]. Austin, TX: ABC-AHP-NCNPR. Botanical Adulterants Prevention Program. 2019. [cit. 25-08-2022]. Available form: https://www.researchgate.net/publication/336124094_Saw_Palmetto_Extract_Laboratory_Guidance_Document. Go to original source...
    6. European Medicines Agency. Assessment Report on Serenoa Repens (W. Bartram) Small, Fructus; European Medicines Agency: Amsterdam, The Netherlands, 2015. [cit. 27-08-2022] Available from: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment.
    7. Braun L, Cohen M. Herbs and Natural Supplements, Volume 2: An Evidence-Based Guide (Vol. 2). Australia. Elsevier Health Sciences. 2014:1384 s.
    8. Dedhia RC, McVary KT. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Urol. 2008;179(6):2119-2125. Go to original source... Go to PubMed...
    9. Wilt T, Ishani A, MacDonald R, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2002;3:CD001423. Go to original source...
    10. Boyle P, Robertson C, Lowe F, et al. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004;93(6):751-756. Go to original source... Go to PubMed...
    11. Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, et al. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies. BJU Int. 2018;122(6):1049-1065. Go to original source... Go to PubMed...
    12. Alcaraz A, Gacci M, Ficarra V, et al. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study. J. Clin. Med. 2022;11(4):967. Go to original source... Go to PubMed...
    13. Tacklind J, MacDonald R, Rutks I, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2012;12:CD001423. Go to original source... Go to PubMed...
    14. National Center for Complementary and Integrative Health. Saw Palmetto [on-line]. Maryland, USA. National Center for Complementary and Integrative Health. ©2015. [cit. 27-08-2022]. Available from: https://www.nccih.nih.gov/health/saw-palmetto.
    15. European Medicines Agency. Assessment Report on Prunus africana (Hook f.) Kalkm., cortex; European Medicines Agency: Amsterdam, The Netherlands, 2015. [cit. 27-08-2022] Available from: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-prunus-africana-hook-f-kalkm-cortex_en.pdf.
    16. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. France: Lavoisier publishing. 1995:915.
    17. Ehsani M, Bartsch S, Rasa SMM, et al. The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2. Oncogene. 2022;41(23):3263-3277. Go to original source... Go to PubMed...
    18. Salinas-Casado J, Esteban-Fuertes M, Carballido-Rodríguez J, et al. Revisión sobre la experiencia y evidencias del Pygeum africanum en Urología. Actas Urol. Esp. 2020;44(1):9-13. Go to original source... Go to PubMed...
    19. Giblo V, Louda M, Pacovský J. Přehled současné farmakoterapie LUTS. Urol. praxi. 2014;15(3):108-114.
    20. Coulson S, Rao A, Beck SL, et al. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. Complement. Ther. Med. 2013;21:172-179. Go to original source... Go to PubMed...
    21. Ishani A, MacDonald R, Nelson D, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am. J. Med. 2000;109(8):654-664. Go to original source... Go to PubMed...
    22. Melo EA, Bertero EB, Rios LA, et al. Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial. Int. Braz. J. Urol. 2002;28(5):418-425.
    23. Cibulka R. URTICA DIOICA L. - kopřiva dvoudomá / pŕhľava dvojdomá; BOTANY.cz: Česká republika, 2022. [cit. 27-08-2022] Available from: https://botany.cz/cs/urtica-dioica/.
    24. European Medicines Agency. Assessment Report on Urtica dioica L., Urtica urens L., their hybrids or their mixtures, radix; European Medicines Agency: Amsterdam, The Netherlands, 2015. [cit. 27-08-2022] Available from: https://www.ema.europa.eu/en/documents/herbal-report/assessment-report-urtica-dioica-l-urtica-urens-l-their-hybrids-their-mixtures-radix-first-version_en.pdf.
    25. Karami A, Sheikhsoleimani M, Memarzadeh R, et al. Urtica Dioica Root Extract on Clinical and Biochemical Parameters in Patients with Benign Prostatic Hyperplasia, Randomized Controlled Trial. Pak. J. Biol Sci. 2020;23(10):1338-1344. Go to original source... Go to PubMed...
    26. Vobořil P. CUCURBITA PEPO L. - tykev obecná / tekvica obyčajná; BOTANY.cz: Česká republika, 2022. [cit. 27-08-2022] Available from: https://botany.cz/cs/cucurbita-pepo/.
    27. European Medicines Agency. Assessment Report on Cucurbita pepo L., semen; European Medicines Agency: Amsterdam, The Netherlands, 2015. [cit. 27-08-2022] Available from: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-cucurbita-pepo-l-semen_en.pdf.
    28. Fornara P, Madersbacher S, Vahlensieck W, et al. Phytotherapy adds to the therapeutic armamentarium for the treatment of mild-to-moderate lower urinary tract symptoms in men. Urol. Int. 2020;104(5-6):333-342. Go to original source... Go to PubMed...
    29. Vahlensieck W, Theurer C, Pfitzer E, et al. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study. Urol. Int. 2015;94(3):286-295. Go to original source... Go to PubMed...
    30. Hong H, Kim CS, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr. Res. Pract. 2009;3(4):323-327. Go to original source... Go to PubMed...
    31. Williamson E, Driver S, Baxter K. Stockley's Herbal Medicines Interactions. London, UK. Pharmaceutical Press 2010:423 s.
    32. Boileau AC, Erdman Jr. JW. Bioavailability of all-trans and cis-Isomers of Lycopene. Exp. Biol. Med. 2002;227(10):914-919. Go to original source... Go to PubMed...
    33. Ross AB, Vuong LT, Ruckle J, et al. Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study. Am. J. Clin. Nutr. 2011;93(6):1263-1273. Go to original source... Go to PubMed...
    34. Schwarz S, Obermüller-Jevic UC, Hellmis E, et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 2008;138(1):49-53. Go to original source... Go to PubMed...
    35. Drugs.com [on-line]. Lycopene Information from Drugs.com; ©2000-2022 [akt. 20-01-2022, cit. 27-08-2022]. Available from: https://www.drugs.com/npp/lycopene.html.
    36. El-Khatib FM, Yafi NR, Yafi FA. Over-the-Counter Supplements and Men's Health. In: Effects of Lifestyle on Men's Health. Academic Press. 2019:281-300. Go to original source...
    37. Chung A, Kini M, Hartigan SM, et al. Nutritional supplementation for benign prostatic hyperplasia. In Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia. Academic Press. 2021:107-111. Go to original source...
    38. Espinosa G, Esposito R. Benign Prostatic Hyperplasia. In Textbook of Natural Medicine (Fifth Edition). Churchill Livingstone. 2020:1189-1195. Go to original source...
    39. West E, Krychman M. Natural aphrodisiacs - a review of selected sexual enhancers. Sex. Med. Rev. 2015;3(4):279-288. Go to original source... Go to PubMed...
    40. Schmidt B, Ferreira C, Alves Passos CL. Resveratrol, curcumin and piperine alter human glyoxalase 1 in MCF-7 breast cancer cells. Int. J. Mol. Sci. 2020;21(15):5244. Go to original source... Go to PubMed...
    41. Sychrová A. Rostlinné přípravky a jejich lékové interakce v běžné ambulantní praxi. Med. praxi. 2021;18(4):266-273. Go to original source...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.